ScholarIQanswers from OpenAlex

Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis

PaperCitations, authors & open-access status

Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis have?

ScholarIQcitation count

Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis has 19 citations in the OpenAlex counts ScholarIQ stores.

When was Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis published?

ScholarIQyear

Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis has 2023 year in the ScholarIQ index.

What is the open-access status of Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis?

ScholarIQoa status

Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis has closed oa status in the ScholarIQ index.

What is the DOI of Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis?

ScholarIQdoi

The DOI for Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis is on the source record.

What is the PMID of Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis?

ScholarIQpmid

The PMID for Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis is on the source record.

What is the OpenAlex record for Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis?

ScholarIQopenalex

The OpenAlex for Highly Effective Therapy Versus Escalation Approaches in Early Multiple Sclerosis is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial